Skip to main content
Lincoln Pharmaceuticals ltd. logo

Lincoln Pharmaceuticals ltd. — Investor Relations & Filings

Ticker · LINCOLN ISIN · INE405C01035 LEI · 3358004B6OBJNW8RTT10 BSE.NS Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2023-09-08 AGM Information
Country IN India
Listing BSE.NS LINCOLN

About Lincoln Pharmaceuticals ltd.

https://www.lincolnpharma.com/

Lincoln Pharmaceuticals Ltd. focuses on the development, manufacturing, and marketing of a diverse range of therapeutic formulations. The organization operates advanced manufacturing facilities certified by international standards, including WHO-GMP. Its portfolio spans multiple areas such as anti-infectives, cardiovascular, gastrointestinal, respiratory, and pain management. The company is recognized for its research and development initiatives, particularly in Novel Drug Delivery Systems (NDDS). Key offerings include specialized treatments for tinnitus and a wide array of formulations in dosage forms like tablets, capsules, liquid orals, and injectables. It maintains a significant global footprint, supplying products to numerous international markets across Africa, Southeast Asia, and Latin America, supported by a robust distribution network for its extensive healthcare catalog.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a submission to stock exchanges (NSE and BSE) regarding the publication of a newspaper advertisement related to the Notice of the 29th Annual General Meeting (AGM) of the company, including details about book closure and e-voting instructions. It references the upcoming AGM scheduled for September 30, 2023, and includes compliance with SEBI regulations. The content is primarily an announcement about the AGM notice publication rather than the AGM materials themselves or the AGM meeting minutes. The document is about informing the exchanges about the advertisement publication, which is typical for regulatory compliance filings. Therefore, this document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or AGM Information (AGM-R). However, since it is about the notice and advertisement of the AGM and not the AGM materials or results, it is more aligned with AGM Information (AGM-R). The document length is 15,000 characters, indicating it is not a brief announcement but a formal submission. Hence, the classification is AGM Information (AGM-R).
2023-09-08 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is a notice dated September 6, 2023, announcing the 29th Annual General Meeting (AGM) of Lincoln Pharmaceuticals Limited to be held on September 30, 2023. It includes details about the meeting agenda such as adoption of audited financial statements for the year ended March 31, 2023, dividend declaration, director appointments, and cost auditor remuneration. The document references compliance with Ministry of Corporate Affairs (MCA) and Securities and Exchange Board of India (SEBI) circulars allowing the AGM to be held via video conferencing. It also mentions that the Annual Report 2022-2023 is being sent electronically and is available on the company website and stock exchange websites. The document is primarily a formal notice of the AGM and its agenda, not the Annual Report itself or any other detailed report. It is lengthy (15,000 characters) but is clearly a notice of meeting and not a report or transcript. Therefore, the appropriate classification is AGM Information (AGM-R).
2023-09-06 English
Book Closure
Notice of Dividend Amount Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the book closure dates for the purpose of determining entitlement to a final dividend for the financial year April 1, 2022 to March 31, 2023. It also mentions the date of the 29th Annual General Meeting (AGM) where the dividend will be approved. The document is short (2942 characters) and serves as an intimation or announcement rather than a detailed report. It does not contain financial statements or detailed financial performance data. The content fits the category of a Notice of Dividend Amount or related announcement about dividend and book closure dates. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2023-08-28 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document contains multiple notices regarding Annual General Meetings (AGMs) of different companies, including details about the date, time, venue, remote e-voting information, book closure dates, and publication of newspaper advertisements related to the AGMs. There is no detailed financial data, management discussion, or full report content. The document primarily serves as an announcement and compliance communication about upcoming AGMs and related voting procedures. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or notices related to it.
2023-08-26 English
Copy of Newspaper Publication
Regulatory Filings
2023-08-11 English
Financial Result Updates
Regulatory Filings
2023-08-10 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.